Cervical phosphorylated insulin-like growth factor binding protein-1 test for the prediction of preterm birth: a systematic review and metaanalysis
- 3 July 2015
- journal article
- review article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 214 (1), 57-73
- https://doi.org/10.1016/j.ajog.2015.06.060
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implicationsThe Lancet, 2012
- Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic reviewThe Lancet, 2012
- The Actim Partus test to predict pre-term birth in asymptomatic high-risk womenJournal of Obstetrics and Gynaecology, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysisBJOG: An International Journal of Obstetrics and Gynaecology, 2011
- The role of phosphorylated insulin-like growth factor binding protein-1 in predicting pre-term labour in twin pregnanciesJournal of Obstetrics and Gynaecology, 2010
- Epidemiology and causes of preterm birthThe Lancet, 2008
- Insulin-like growth factor-binding protein-1 (IGFBP-1) in cervical secretions as a predictor of preterm deliveryThe Journal of Maternal-Fetal & Neonatal Medicine, 2008
- Predicting preterm delivery in asymptomatic patients with prior preterm delivery by measurement of cervical length and phosphorylated insulin‐like growth factor‐binding protein‐1Ultrasound in Obstetrics & Gynecology, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003